Harrow, Inc. (HROW)
NASDAQ: HROW · Real-Time Price · USD
32.13
-0.03 (-0.09%)
At close: Nov 19, 2026, 4:00 PM EST
31.88
-0.25 (-0.78%)
After-hours: Nov 19, 2026, 7:43 PM EST
Harrow Market Cap
Harrow has a market cap or net worth of $1.21 billion as of November 19, 2026. It is the 8,637th most valuable company in the world and the 2,061st biggest in the United States. Its market cap has decreased by 18.05% in one year.
Market Cap
1.21B
Enterprise Value
1.43B
1-Year Change
-18.05%
Global Rank
Country Rank
#2,061 United States
Category
ChartMarket Cap Chart
Since October 1, 2007, Harrow's market cap has increased from $22.20M to $1.21B, an increase of 5,332.16%. That is a compound annual growth rate of 23.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 1.21B | -33.55% |
| Dec 31, 2025 | 1.81B | 51.88% |
| Dec 31, 2024 | 1.19B | 203.81% |
| Dec 29, 2023 | 393.30M | -2.79% |
| Dec 30, 2022 | 404.60M | 74.10% |
| Dec 31, 2021 | 232.40M | 31.60% |
| Dec 31, 2020 | 176.60M | -9.81% |
| Dec 31, 2019 | 195.80M | 47.77% |
| Dec 31, 2018 | 132.50M | 279.66% |
| Dec 29, 2017 | 34.90M | 5.44% |
| Dec 30, 2016 | 33.10M | -50.67% |
| Dec 31, 2015 | 67.10M | -3.31% |
| Dec 31, 2014 | 69.40M | 130.56% |
| Dec 31, 2013 | 30.10M | -53.19% |
| Dec 31, 2012 | 64.30M | 3,284.21% |
| Dec 30, 2011 | 1.90M | -85.04% |
| Dec 31, 2010 | 12.70M | -45.96% |
| Dec 31, 2009 | 23.50M | 51.61% |
| Dec 31, 2008 | 15.50M | -58.89% |
| Dec 31, 2007 | 37.70M | 69.82% |
| Oct 1, 2007 | 22.20M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Trulieve Cannabis | 1.94B |
| BioCryst Pharmaceuticals | 1.93B |
| Eton Pharmaceuticals | 1.84B |
| Alvotech | 1.56B |
| ANI Pharmaceuticals | 1.48B |
| Pacira BioSciences | 1.46B |
| Phibro Animal Health | 1.42B |
| Amphastar Pharmaceuticals | 1.24B |